Browse > Article
http://dx.doi.org/10.5012/bkcs.2009.30.1.083

Synthesis of Novel Allylthio Heterocyclo(or aryl)alkylaminopyridazines and Their Anticancer Activity against SK-Hep-1 Cells  

Lee, Myung-Sook (College of Pharmacy, Duksung Women’s University)
Kim, Eun-Sook (College of Pharmacy, Duksung Women’s University)
Moon, A-Ree (College of Pharmacy, Duksung Women’s University)
Park, Myung-Sook (College of Pharmacy, Duksung Women’s University)
Publication Information
Bulletin of the Korean Chemical Society / v.30, no.1, 2009 , pp. 83-91 More about this Journal
Abstract
To develop new anticancer agents, 3-allylthio-6-aminopyridazine derivatives were synthesized from maleic anhydrides or phthalic anhydrides by formation of a pyridazine nucleus, dichlorination, allylthiolation and amination. The pyridazine nuclei were obtained by condensing a hydrazine monohydrate with maleic anhydride. An allylthio group as a pharmacologically active group was introduced into one side of a pyridazine ring. Arylalkylamines with benzene or pyridine moieties or heterocycloalkylamines with heterocycle moieties such as morpholine, piperidine, or pyrrolidine were also introduced into the para-position of allylthio pyridazine. These new compounds showed antiproliferative activities against SK-Hep-1 human liver cancer cells in MTT assays. These compounds are thus promising candidates for chemotherapy of hepatocellular carcinomas. Two compounds, 20c and 22a, showed higher potencies for inhibiting growth of hepatocellular carcinoma cells than did K6 ($ID_50$=1.08 mM). This suggests the potential anticancer activity of these two compounds.
Keywords
Allylthiopyridazines; Aminopyridazines; Amination; Anticancer activity; SK-Hep-1;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 3
연도 인용수 순위
1 Tisler, M.; Stanovnik, B. Advances in Heterocyclic Chemistry; Katritzky & Boulton, Eds.; 1984; Vol. 3, pp 1-56
2 Song, J. H.; Kim, S. G.; No, Z. S.; Hyun, Y. L.; Jeon, D. J.; Kim, I. Bull. Korean Chem. Soc. 2008, 29, 1467   DOI   ScienceOn
3 Contreras, J. M.; Parrot, I.; Sippl, W.; Rival, Y. M.; Wermuth, C. G. J. Med. Chem. 2001, 44, 2707   DOI   ScienceOn
4 Parrot, I.; Wermuth, C. G.; Hibert, M. Tetrahedron Lett. 1999, 40, 7975   DOI   ScienceOn
5 Wermuth, C. G.; Bourguignon, J.; Schlewer, G.; Gies, J.; Schoenfelder, A.; Melikian, A.; Bouchet, M. J. Med. Chem. 1987, 30, 239   DOI
6 Shin, H. S.; Kwon, S. K. Arch. Pharm. Res. 2003, 5, 351
7 Wermuth, C. G.; Schlewer, G.; Bourguignon, J. J.; Maghiros, G.; Bouchet, M. J.; Moire, C.; Kan, J. P.; Worms, P.; Biziere, K. J. Med. Chem. 1989, 32, 528   DOI
8 Kleemann, A.; Engel, J. Pharmaceutical Substances, 4th ed.; 2001; pp 1340-1342
9 Contreras, J. M.; Rival, Y. M.; Chayer, S.; Bourguignon, J. J.; Wermuth, C. G. J. Med. Chem. 1999, 42, 730   DOI   ScienceOn
10 Lee, J. I.; Park, H.; Yun, Y. S.; Kwon, S. K. J. Kor. Chem. Soc. 2001, 45, 386
11 Kwon, S. K.; Kim, M. K. Yakhak Hoeji 2002, 46, 89
12 Kwon, S. K. Yakhak Hoeji 2002, 46, 155
13 Kwon, S. K.; Moon, A. R. Arch. Pharm. Res. 2005, 4, 391
14 Jung, M. Y.; Kwon, S. K.; Moon, A. Eur. J. Cancer 2001, 37, 2104   DOI   ScienceOn
15 Parrot, I.; Rival, Y.; Wermuth, C. G. Synthesis 1999, 7, 1163
16 Park, E. H.; Park, M. S. Yakhak Hoeji 2005, 49(1), 56
17 Park, E. H.; Park, M. S. J. Kor. Chem. Soc. 2007, 51(3), 244   DOI   ScienceOn
18 Kwon, S. K.; Lee, M. S. Yakhak Hoeji 2005, 49(6), 505
19 Lu, Z.; Twieg, R. J. Tetrahedron 2005, 61, 903   DOI   ScienceOn
20 Eldrup, A. B.; Dahl, O.; Nielsen, P. J. Am. Chem. Soc. 1997, 119, 1116   DOI   ScienceOn
21 Beletskaya, I.; Bessmertnykh, G.; Guilard, R. Tetrahedron Lett. 1999, 40, 6393   DOI   ScienceOn
22 Tewari, A.; Hein, M.; Zapt, A.; Beller, M. Tetrahedron 2005, 61, 9705   DOI   ScienceOn
23 Yokoyama, R.; Ito, S.; Okujima, T.; Kubo, T.; Yasunami, M.; Tajiri, A.; Morita, N. Tetrahedron 2003, 59, 8191   DOI   ScienceOn